Table 4.
Multivariate analysis results of the risk factors for CMBs in different regions.
| Lobar CMBs (n = 67) OR (95%CI) |
Deep CMBs (n = 47) OR (95%CI) |
Infratentorial CMBs (n = 27) OR (95%CI) |
Mixed CMBs (n = 55) OR (95%CI) |
|
|---|---|---|---|---|
| Age | 1.02 (0.94–1.10) | 1.13 (1.04–1.24) | 0.95 (0.83–1.08) | 1.04 (0.97–1.12) |
| Smoking | 2.35 (0.62–8.89) | 6.02 (1.53–23.71) | 0.40 (0.03–5.65) | 2.37 (0.70–7.95) |
| Hypertension | 0.64 (0.24–1.71) | 12.54 (2.21–71.28) | 4.40 (0.78–24.81) | 2.11 (0.78–5.70) |
| Antithrombotic | 0.01 (0.00–0.29) | 0.15 (0.02–1.40) | 1.48 (1.04–2.39) | 0.43 (0.07–5.70) |
| medication | ||||
| Lipid-lowering | 9.46 (4.20–20.65) | 2.55 (0.22–28.94) | 3.48 (1.44–8.39) | 3.27 (0.52–20.79) |
| medication | ||||
| TC | 0.26 (0.13–0.54) | 0.26 (0.12–0.55) | 0.52 (0.19–1.40) | 0.59 (0.32–1.06) |
| TG | 2.57 (1.14–5.83) | 4.48 (1.94–10.39) | 1.19 (0.31–4.59) | 2.91 (1.29–6.59) |
| HDL-C | 0.64 (0.10–4.17) | 1.28 (0.12–13.64) | 0.19 (0.01–5.86) | 0.99 (0.15–6.69) |
| Aβ1-42 | 1.02 (1.00–1.03) | 1.01 (0.99–1.03) | 1.02 (0.99–1.04) | 1.01 (0.99–1.03) |
| pTau-181 | 0.99 (0.95–1.04) | 0.95 (0.89–1.02) | 1.07 (0.99–1.15) | 0.99 (0.95–1.05) |
Note: TC (Total cholesterol), TG (Triglyceride), HDL-C (High-density lipoprotein cholesterol).